Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H10AsN2O4.Na |
Molecular Weight | 296.0874 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].NC(=O)CNC1=CC=C(C=C1)[As](O)([O-])=O
InChI
InChIKey=UEYIAABRKWHXJV-UHFFFAOYSA-M
InChI=1S/C8H11AsN2O4.Na/c10-8(12)5-11-7-3-1-6(2-4-7)9(13,14)15;/h1-4,11H,5H2,(H2,10,12)(H2,13,14,15);/q;+1/p-1
Tryparsamide is an arsenic compound with activity against Spirochaetes bacteria. Tryparsamide is used in the treatment of syphilis and African sleeping sickness. For decades Tryparsamide remained the standard treatment for trypanosomiasis. Tryparsamide has two remarkable properties: first, it increases the resistance of the individual by improving his general physical status; and, second, the high penetrability for nervous tissue which it possesses may increase the potential spirocheticidal action of the drug.
CNS Activity
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20315250
The proper dosage for the average individual is to 3 grams of the drug. This amount dissolved in 10-20 cc. of sterile distilled water is given weekly. It may be given subcutaneously, intramuscularly or intravenously. The intravenous route is the preferable one to use. It should be given slowly by the syringe method.
Route of Administration:
Parenteral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C52588
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
435
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
PRIMARY | |||
|
C66646
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
PRIMARY | |||
|
2050
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
PRIMARY | |||
|
209-070-9
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
PRIMARY | |||
|
23665572
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
PRIMARY | |||
|
DTXSID301046341
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
PRIMARY | |||
|
C073345
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
PRIMARY | |||
|
554-72-3
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
PRIMARY | |||
|
m11244
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
PRIMARY | Merck Index | ||
|
3636
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
PRIMARY | |||
|
4NN21HAX16
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
PRIMARY | |||
|
100000077468
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
PRIMARY | |||
|
SUB11359MIG
Created by
admin on Fri Dec 15 15:34:52 GMT 2023 , Edited by admin on Fri Dec 15 15:34:52 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD